Nuvectis Pharma
NVCT
NVCT
47 hedge funds and large institutions have $24.2M invested in Nuvectis Pharma in 2025 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
+14
Holders Change %
+42.42%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
15
Reduced
6
Closed
8
Calls
$569K
Puts
$495K
Net Calls
+$74K
Net Calls Change
-$332K
Top Buyers
| 1 |
BlackRock
New York
|
+$4.29M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.49M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.12M |
| 4 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$887K |
| 5 |
State Street
Boston,
Massachusetts
|
+$641K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$756K |
| 2 |
Millennium Management
New York
|
-$672K |
| 3 |
Goldman Sachs
New York
|
-$446K |
| 4 |
Jane Street
New York
|
-$413K |
| 5 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$321K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Squarepoint
New York
| – | -$108K | -11,012 | Closed |
|
|
BZWA
52
Blue Zone Wealth Advisors
Los Angeles,
California
| – | -$102K | -10,424 | Closed |
|
53
Citadel Advisors
Miami,
Florida
| – | -$101K | -10,344 | Closed |
|
|
JG
54
Jain Global
New York
| – | -$99.2K | -10,154 | Closed |
|